Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

398
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
398
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

355
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy: the ANGEL-TNK randomized clinical trial.

CJEM·2026
Same author

Surveillance Outcomes in an Australian Cohort Undergoing Piecemeal Polypectomy for Conventional Adenomas and Serrated Lesions.

Digestive diseases and sciences·2026
Same author

Rapid detection and quantification of the fastidious pathogen Streptococcus pneumoniae directly from whole blood using InfectID-BSI: A multiplex qPCR test to augment clinical acumen in sepsis.

Journal of critical care·2026
Same author

Acute Traumatic Aortic Injury: What the Radiologist Needs to Know.

Tomography (Ann Arbor, Mich.)·2026
Same author

Understanding heterogeneity in the pathogenesis and drug responses of ulcerative colitis through single-cell and spatial transcriptomics.

Frontiers in immunology·2026
Same author

Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics.

JGH open : an open access journal of gastroenterology and hepatology·2026

Related Experiment Video

Updated: Aug 28, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.6K

A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's

James Irwin1,2,3, Anton Lord4, Emma Ferguson5

  • 1QIMR Berghofer Medical Research Institute, Brisbane, Australia. jamesi@mdhb.health.nz.

Digestive Diseases and Sciences
|September 20, 2022
PubMed
Summary

Longitudinal laboratory testing can predict severe intestinal complications in Crohn's disease patients. A score based on albumin, mean cell volume, platelets, and C-reactive protein identifies at-risk individuals for earlier intervention.

Keywords:
BiomarkersCrohn’s diseaseFistulaInflammatory bowel diseasesPerforationStenosis

More Related Videos

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.3K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Related Experiment Videos

Last Updated: Aug 28, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.6K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.3K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Predictive Analytics

Background:

  • Crohn's disease can lead to severe intestinal complications like stenosis, fistulization, and perforation.
  • Early prediction of these complications is crucial for timely treatment adjustments.

Purpose of the Study:

  • To investigate the correlation between longitudinal laboratory test results and the occurrence of subsequent intestinal complications in Crohn's disease patients.
  • To develop a predictive tool for identifying patients at higher risk of developing intestinal complications.

Main Methods:

  • An observational cohort study analyzed data from Crohn's disease patients between 1994 and 2016.
  • Cox regression was employed to identify laboratory variables associated with intestinal complications (fistula, stenosis, perforation).
  • A clinical scoring tool was designed based on key laboratory parameters.

Main Results:

  • In 246 patients, 134 complications were observed over a median of 5.72 years.
  • The minimum or maximum laboratory values within a one-year window were most predictive of subsequent complications.
  • A Longitudinal Laboratory score (≥2) demonstrated 62% sensitivity and 91% specificity in predicting complications.

Conclusions:

  • Consistent changes in serum albumin, mean cell volume, platelet count, and C-reactive protein levels are associated with increased risk of complications.
  • Longitudinal laboratory testing offers a rational basis for escalating therapy in Crohn's disease management.
  • The developed scoring tool can aid in the early identification of patients requiring intensified treatment.